Memantine for Treatment-Resistant OCD — POYUROVSKY et al. 162 (11): 2191 — American Journal of Psychiatry

As the abstract points out a case study with one participant is rather limited but this is rather exciting.

Memantine is a relatively new drug recently approved in the US for treating Alzheimer’s. It has been in use in Germany for ten years or so.